Douglas Steinberg(dsteinberg@the-scientist.com) | Nov 20, 2005 | 6 min read
Potential perils from bioterrorism to bird flu are increasingly pushing proteomics researchers to identify molecules involved in the infection process.
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.
Modifying mouse memories; mitochondria-disrupting antibiotics; horizontal gene transfer across animals; T cells target dengue; optogenetics without the genetics